Bryan E. Roberts Ph.D. — Co-Founder, Chairman & Lead Independent Director at Castlight Health

Dr. Bryan E. Roberts, Ph.D., serves as a Partner and the General Partner at Venrock Associates. Dr. Roberts joined Venrock in 1997 as a Kauffman Fellow and focuses on investments in biotechnology, healthcare information technology, diagnostics, and medical devices. He invests broadly across healthcare. Dr. Roberts co-founded Castlight Health, Inc. in 2008. He founded Lyra Health, Inc. in 2015. From 1989 to 1992, Dr. Roberts held corporate finance positions at Kidder Peabody & Co., Inc. He serves as the Chairman of the Board at Kyruus, Inc. Dr. Roberts serves as the Chairman of Achaogen, Inc., since December 2009 and serves as its Director since August 2004. He serves as the Chairman of the Board of Castlight Health, Inc. since October 25, 2017 and its Lead Independent Director. Dr. Roberts served as the Chairman at Castlight Health, Inc. since 2010 until April 3, 2017. He served as the Chairman at Ironwood Pharmaceuticals, Inc. since July 2010 until 2015. Dr. Roberts serves as a Director at ADVANCE Medical, Inc. since June 1, 2011. He serves as a Director at Doctor on Demand, Inc. since August 6, 2014. Dr. Roberts serves as a Director at 10X Genomics, Inc. since November 2013. He serves as a Director at PowerVision, Inc. and First Genetic Trust, Inc. Dr. Roberts serves as a Director at Ikaria, Inc. and Intarcia Therapeutics, Inc. since March 2007. He serves as a Director at Adavium Medical, Inc., Hua Medicine (Shanghai) Ltd., Aria Diagnostics, Inc., and Grand Rounds, Inc. Dr. Roberts serves as a Director at Ariosa Diagnostics, Inc. since May 2010. He serves as a Director at Devoted Health, Inc. Dr. Roberts serves as a Director at Stride Health, Inc., Lyra Health, Inc. and REN Pharmaceuticals, Inc. He serves as a Director at Castlight Health, Inc. since April 2008. Dr. Roberts serves as a Board observer at CloudFlare. He serves as a Member of Advisory Board at Mountain Group Capital, LLC. Dr. Roberts serves as a Member of Advisory Board at Limestone Fund, LLC. He served as a Director at Vitae Pharmaceuticals, Inc. since 2001 until July 26, 2016. Dr. Roberts served as a Director at Fate Therapeutics, Inc. until August 2013; CodeRyte, Inc.; Cerulean Pharma Inc.; Nanosys, Inc. since May 2003; and athenahealth, Inc. from 1999 to June 11, 2009. He served as a Director at Ironwood Pharmaceuticals, Inc. since 2001 until June 1, 2016. Dr. Roberts served as a Director at Zeltiq Aesthetics, Inc. since 2005 until June 16, 2016. He served as a Director at Sirna Therapeutics, Inc. since April 2003. Dr. Roberts served as an Independent Director at Xenoport, Inc. from 2000 to August 1, 2007. He served as a Member of the Board of Directors at ConsultingMD Inc., Satiety, Inc., Surface Logix, Inc., and Pathwork Diagnostics, Inc. In 2006, The Aspen Institute named him a Henry Crown Fellow and was named to healthspottr's 2009 Future Health 100 list. Dr. Roberts is the only healthcare investor to rank on Forbes' Midas List seven times, 2008 - 2016. Dr. Roberts holds a Ph.D. in Chemistry and Chemical Biology from Harvard University in 1997 and a B.A., Phi Beta Kappa, with high honors in Chemistry from Dartmouth College in 1989. Dr. Roberts holds Doctorate in Philosophy from the University of Oxford.